Dawn P Richards: The patient as a person – The BMJ
We need to recognise individuals as more than simply a patient Wife. Scientist. Daughter. Aunt. Friend. Entrepreneur. Volunteer. Advocate. Consultant. Traveller. Person who lives with rheumatoid arth...
Ontario Healthcare Tech Scene, Hey
Two decades ago I would occasionally find myself in Ontario given the developing innovation corridor between Toronto and Waterloo, affectionately referred to as “Silicon Valley North.” Last week I visited again and saw the emergence of a strong healthcare tech ecosystem, leveraging historic strengths in telecom infrastructure and the recent (and significant) commitments to the…
U of T researchers develop new generation CAR T-cells for cancer therapy
With CAR T-cell therapy one of the promising technologies emerging in targeted cancer treatment, University of Toronto scientists have taken a step forward in improving the potential effectiveness of this therapeutic approach.
Info Session: Outbound Trade Mission to the Netherlands 2018
Learn about our upcoming Human Health & Sciences Trade Mission to the Netherlands, April 22-26 Why are we going? Home to a cluster of more than 2,200 human health & sciences companies and research organizations, all within a 120-mile radius and actively seeking partnerships The World Trade Centers Association (WTCA) 2018 General Assembly is taking place in Leeuwarden–the program includes an international business-to-business matchmaking event You should attend if: You are a trade-ready Canadian company in the Human Health & Sciences sector seeking export or partnership opportunities Session Content: Why join this trade mission? Mission goals and objectives Application process Participation costs and funding opportunities
UHN Start-up AVROBIO, Inc. Announces $60 Million Series B Financing to Advance Gene Therapy Pipeline for Lysosomal Storage Disorders and Apply Lentiviral Platform to Other Genetic Diseases | TDC
Company to initiate Phase 2 trial with lead gene therapy, AVR‑RD‑01, based on promising initial clinical data in Fabry disease Strong investor syndicate supports multi-product portfolio with three additional gene therapies for Gaucher disease, cystinosis and Pompe disease
J&J Innovation Podcast: 012 - Changing the Way We Think About CNS Drug Development
On this episode of the J&J Innovation Podcast, Bill Martin, CSO of Blackthorn Therapeutics, talks about the work they are doing to change the way we think about drug development, specifically as it pertains to treating brain disorders.
LSO - LSO Annual Awards Presentation -
MEMBER LOGIN Email: Password: Forgot Password? | Become a Member I am part of a Corporate Membership LSO Annual Awards Presentation Wednesday, February 28, 2018 LSO 2018 Celebra...
FACIT Falcons' Fortunes Pitch Competition
FACIT Falcons' Fortunes 2018 - Pitch Competition Concept: Falcons’ Fortunes (based on the popular TV series Dragons’ Den) invites Ontario-based entrepreneurs working in the oncology space to pitch in...